Literature DB >> 1677795

Effects of histamine H1- and H2-receptor antagonists on cardiovascular function during systemic anaphylaxis in guinea pigs.

S B Felix1, G Baumann, M Niemczyk, T Hashemi, G Ochsenfeld, Z Ahmad, S Shirani, H Blömer.   

Abstract

The heart is a target organ of anaphylaxis. In isolated perfused hearts, an anaphylactic reaction is characterized by arrhythmias, coronary constriction and severe impairment of ventricular contractile force. Various mediators such as PAF, thromboxane A2 and leukotrienes are responsible for anaphylactic coronary constriction and negative inotropic effects. The cardiac effects of anaphylactic histamine release are related to the stimulation of two antagonistic receptor types. Histamine induces atrioventricular conduction delay and constriction of the epicardial coronary vessels via H1-receptor stimulation. H2-receptors, however, mediate coronary vasodilation and an increase in heart rate and myocardial contractility. It may therefore be concluded that administration of histamine H2-receptor antagonists is disadvantageous. During anaphylactic states, the cardiodepressive effects of the other mediators of anaphylaxis are unmasked, resulting in a sustained coronary constriction and impairment of myocardial contractility. To verify this speculation, we investigated the effects of H1- and H2-receptor antagonists on cardiovascular function of guinea pigs during systemic anaphylaxis. In guinea pigs, sensitization was produced by subcutaneous application of ovalbumin. Fourteen days after sensitization, the effects of an intravenous infusion of ovalbumin were tested in the anesthetized artificially ventilated guinea pigs. The renewed administration of the antigen induced severe cardiac dysfunction. Within a few minutes, cardiac output markedly decreased and left ventricular end-diastolic pressure increased significantly, indicating left ventricular pump failure. In the same time range, ECG recordings uniformly showed signs of acute myocardial ischemia. In addition, arrhythmias occurred in terms of an atrioventricular block.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677795     DOI: 10.1007/bf01980881

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  26 in total

1.  The role of histamine in cardiac anaphylaxis; characterization of histaminergic H1- and H2-receptor effects.

Authors:  S B Felix; G Baumann; S Helmus; U Sattelberger
Journal:  Basic Res Cardiol       Date:  1988 Sep-Oct       Impact factor: 17.165

2.  Pharmacological modification of leukotriene release and coronary constrictor effect in cardiac anaphylaxis.

Authors:  P Weinerowski; G Wittmann; U Aehringhaus; B A Peskar
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1985

3.  Histamine receptors in the human heart.

Authors:  R Ginsburg; M R Bristow; E B Stinson; D C Harrison
Journal:  Life Sci       Date:  1980-06-30       Impact factor: 5.037

4.  Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate.

Authors:  J H McNeill; S C Verma
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

5.  A new highly potent and short-acting analgesic, carfentanyl (R 33799), in combination with the hypnotic agent, etomidat (R 26490), as a method of anaesthesia in guinea pigs.

Authors:  G Neumann; W Erhardt; B Oberhuber; R Fritsch; G Blümel
Journal:  Res Exp Med (Berl)       Date:  1980

6.  Pharmacological characterization of cardiac histamine receptors: sensitivity to H1-and H2-receptor agonists and antagonists.

Authors:  R Levi; N Capurro; C H Lee
Journal:  Eur J Pharmacol       Date:  1975-02       Impact factor: 4.432

7.  Systemic anaphylaxis--separation of cardiac reactions from respiratory and peripheral vascular events.

Authors:  S B Felix; G Baumann; W E Berdel
Journal:  Res Exp Med (Berl)       Date:  1990

8.  Hemodynamic changes in human anaphylaxis.

Authors:  H J Silverman; C Van Hook; E F Haponik
Journal:  Am J Med       Date:  1984-08       Impact factor: 4.965

9.  Cardiac contractile and metabolic effects mediated via the myocardial H2-receptor adenylate cyclase system. Characterization of two new specific H2-receptor agonists, impromidine and dimaprit, in the guinea pig and human myocardium.

Authors:  G Baumann; S B Felix; J Schrader; C D Heidecke; G Riess; W D Erhardt; L Ludwig; U Loher; F Sebening; H Blömer
Journal:  Res Exp Med (Berl)       Date:  1981

10.  Thromboxane and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro.

Authors:  G Allan; R Levi
Journal:  J Pharmacol Exp Ther       Date:  1981-04       Impact factor: 4.030

View more
  6 in total

1.  Transient 2:1 atrioventricular block following anaphylactic reaction to low-ionic strength computed tomography contrast agent.

Authors:  Aneez Mohamed; Jason Andrade; Michael Bayliss; Graham C Wong
Journal:  Can J Cardiol       Date:  2008-12       Impact factor: 5.223

Review 2.  Therapeutic controversies in the management of acute anaphylaxis.

Authors:  A F Brown
Journal:  J Accid Emerg Med       Date:  1998-03

Review 3.  Anaphylactic shock: mechanisms and treatment.

Authors:  A F Brown
Journal:  J Accid Emerg Med       Date:  1995-06

4.  Electrocardiographic changes associated with anaphylaxis in a patient with normal coronary arteries.

Authors:  M B Engrav; M Zimmerman
Journal:  West J Med       Date:  1994-12

Review 5.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

6.  Histamine-induced vasodilatation in the human forearm vasculature.

Authors:  Euan A Sandilands; Jane Crowe; Hayley Cuthbert; Paul J Jenkins; Neil R Johnston; Michael Eddleston; D Nicholas Bateman; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.